Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Nuvectis Pharma, Inc.’s reported figures.
The source filing: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055318
FAQ
- What is Nuvectis Pharma, Inc.'s EBIT?
- Nuvectis Pharma, Inc. (NVCT) reported EBIT of -$6.26M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s EBIT changed year-over-year?
- Nuvectis Pharma, Inc.'s EBIT decreased by 12.4% year-over-year, from -$5.57M to -$6.26M.
- What is the long-term trend for Nuvectis Pharma, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s EBIT has grown at a 20.9% compound annual growth rate (CAGR), from -$12.89M to -$27.57M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Nuvectis Pharma, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude